OFELIA
BANIANDRÉS RODRÍGUEZ
Profesora asociada de Ciencias de la Salud
Hospital Universitari de Tarragona Joan XXIII
Tarragona, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Tarragona Joan XXIII (4)
2024
-
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
International Journal of Dermatology, Vol. 63, Núm. 4, pp. 503-511
-
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice
Experimental Dermatology, Vol. 33, Núm. 8
2023
-
High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting
International Journal of Dermatology
2021
-
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain
Dermatology and Therapy, Vol. 11, Núm. 6, pp. 2207-2215